Teza Capital Management LLC Horizon Therapeutics Public LTD CO Transaction History

Teza Capital Management LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2023 Feb 22, 2024	BUY	$107.32 - $113.5 $2.52 Million - $2.67 Million	23,484 New	23,484 $2.56 Million
Q1 2023 May 15, 2023	BUY	$107.32 - $113.5 $4.55 Million - $4.81 Million	42,351 New	42,351 $4.62 Million
Q3 2022 Nov 14, 2022	SELL	$58.92 - $84.67 $515,962 - $741,455	-8,757 Reduced 58.55%	6,199 $384,000
Q2 2022 Aug 15, 2022	BUY	$79.4 - $116.36 $1.19 Million - $1.74 Million	14,956 New	14,956 $1.19 Million
Q3 2021 Nov 10, 2021	SELL	$91.91 - $110.37 $234,921 - $282,105	-2,556 Closed	0 $0
Q2 2021 Aug 06, 2021	BUY	$86.24 - $95.92 $220,429 - $245,171	2,556 New	2,556 $239,000
Q2 2020 Aug 10, 2020	SELL	$30.2 - $56.98 $393,324 - $742,107	-13,024 Closed	0 $0
Q1 2020 May 11, 2020	BUY	$24.87 - $38.56 $323,906 - $502,205	13,024 New	13,024 $386,000

2.07M

20K

Ticker HZNP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 230,384,000
Description
Horizon Therapeutics Public Limited Company, a biotechnology company, focuses on the discovery, development, and commercialization of medicines that address critical needs for people impacted by rare, autoimmune, and severe inflammatory diseases. The company operates in two segments, Orphan and Inflammation. Its portfolio comprises 12 medicines ...

Get notified when there are updates to the investment portfolio of Teza Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Teza Capital Management LLC with notifications on news.